Business

Veri Medtech (VRHI) Announces Stock Buyback Program

Veri Medtech (VRHI) Announces Stock Buyback Program.

articleVeri Medtech Holdings Inc.June 27, 20254/company/vrhi/news/veri-medtech-vrhi-announces-stock-buyback-program
Veri Medtech (VRHI) Announces Stock Buyback Program

About this update from Veri Medtech Holdings Inc.

[{"type":"text","content":"Veri Medtech (VRHI) Announces Stock\r\nBuyback Program\r\nAuthorizing\r\nRepurchase Up To 1,000,000 shares\r\n \r\nFOR\r\nIMMEDIATE RELEASE\r\n \r\nNew York,\r\nNY,  June 27, 2025.  GlobeNewswire –\r\nVeri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) (\"Veri\r\nMedtech\"), healthcare technology platform, announced today a 2025 Stock\r\nBuyback Program (the “2025 Program”) authorizing the Company to repurchase up\r\nto 1,000,000 shares of its VRHI common stock in the open market or\r\nprivately-negotiated transactions.  For more information on Veri Medtech\r\n(VRHI), please visit: www.verimedtech.com. \r\n About\r\nVeri Medtech (OTC Markets: VRHI):\r\nVeri Medtech is a publicly-traded healthcare technology company that offers\r\nalternative medicine, personalized diagnostics, and wellness medication on\r\ndemand. The company leverages telehealth infrastructure, diagnostic\r\nintelligence, and scalable digital systems to meet the growing demand for\r\naccessible, stigma-free healthcare. Strategically positioned for growth, Veri\r\nMedTech actively explores acquisitions that complement its core capabilities\r\nand enhance patient engagement across emerging sectors of alternative medicine,\r\nlongevity, and wellness science. With a strong integration and operational\r\nefficiency track record, the company drives accelerated revenue through the\r\ncontinuous generation of high-value patient databases and recurring service\r\nmodels. With a commitment to innovation and patient-centric care, Veri MedTech\r\ncontinues to expand its services and reach, aiming to make personalized\r\nhealthcare more accessible and effective for all. For more information, please\r\nvisit: www.VeriMedTech.com\r\n \r\nAbout\r\nDosePop: DosePop,\r\na wholly-owned subsidiary of publicly-traded Veri Medtech Holdings - OTC\r\nMarkets (“VRHI”), provides a one-stop healthcare technology platform for mental\r\nand physical health, all designed to empower you to take charge of your\r\nwell-being. From weight loss solutions to anti-aging, our treatments are backed\r\nby science and administered by licensed professionals.  For more information, please visit: www.DosePop.com\r\n \r\nAbout\r\nVeriheal: Veriheal,\r\na wholly-owned subsidiary of publicly-traded Veri Medtech Holdings - OTC\r\nMarkets (“VRHI”) is a h...

More updates from Veri Medtech Holdings Inc.